Clik here to view.
Philippines senator who led the country's brutal war on drugs apologized for...
A Filipino senator apologized on Monday after responding to the death of a three-year-old girl shot during a drug raid by saying "shit happens."Last month, three-year-old Kateleen Myca Ulpina was shot...
View ArticleClik here to view.
People who take drugs like Ecstasy at festivals may unknowingly be using...
Electronic dance music party-goers may be unknowingly exposed to ketamine, an addictive anesthetic, according to a new study.NYU researchers found that 30% of people who said they did not take...
View ArticleClik here to view.
An erectile dysfunction drug left men with 'intensely blue' vision and...
A hospital in Turkey has treated 17 men in two years who took double the recommended dose of erectile dysfunction drug sildenafil and reported vision problems, including "intense" blue...
View ArticleClik here to view.
Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 billion Johnson &...
Momenta Pharmaceuticals surged as much as 69% on Wednesday after reaching an agreement to be acquired by Johnson & Johnson.The deal values Momenta at $52.50 per share, a 70.4% premium to its...
View ArticleClik here to view.
2 biotech stocks plummet more than 25% after the FDA rejects their drug...
Three biotechnology stocks plummeted on Wednesday after the FDA issued two separate complete response letters, or CRLs, for two separate drugs.On Tuesday after the market close, Gilead received a CRL...
View ArticleClik here to view.
Roche jumps 2% after unveiling COVID-19 antibody test, and on finding its...
Summary List PlacementShares in Swiss healthcare group Roche rose 2% on Friday after the company launched a new test to measure COVID-19 antibodies, and provided evidence its drugs reduce need for...
View ArticleClik here to view.
Remdesivir, the only antiviral authorized for COVID-19 in the US, did not...
Summary List PlacementRemdesivir, the only antiviral drug authorized to treat COVID-19 in the US, did not stop patients from dying or shorten their hospital stays in a massive World Health Organization...
View ArticleClik here to view.
Immutep jumps 13% after getting fast-track status for its drug to treat head...
Summary List PlacementImmutep jumped as much as 13% to two-week highs on Thursday after the biotechnology company announced that its lead drug candidate for recurrent or metastatic head and neck cancer...
View Article
